Loading…
Epigenetic control of intestinal barrier function and inflammation in zebrafish
The intestinal epithelium forms a barrier protecting the organism from microbes and other proinflammatory stimuli. The integrity of this barrier and the proper response to infection requires precise regulation of powerful immune homing signals such as tumor necrosis factor (TNF). Dysregulation of TN...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS 2015-03, Vol.112 (9), p.2770-2775 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The intestinal epithelium forms a barrier protecting the organism from microbes and other proinflammatory stimuli. The integrity of this barrier and the proper response to infection requires precise regulation of powerful immune homing signals such as tumor necrosis factor (TNF). Dysregulation of TNF leads to inflammatory bowel diseases (IBD), but the mechanism controlling the expression of this potent cytokine and the events that trigger the onset of chronic inflammation are unknown. Here, we show that loss of function of the epigenetic regulator ubiquitin-like protein containing PHD and RING finger domains 1 ( uhrf1 ) in zebrafish leads to a reduction in tnfa promoter methylation and the induction of tnfa expression in intestinal epithelial cells (IECs). The increase in IEC tnfa levels is microbe-dependent and results in IEC shedding and apoptosis, immune cell recruitment, and barrier dysfunction, consistent with chronic inflammation. Importantly, tnfa knockdown in uhrf1 mutants restores IEC morphology, reduces cell shedding, and improves barrier function. We propose that loss of epigenetic repression and TNF induction in the intestinal epithelium can lead to IBD onset.
Significance Inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis, are intestinal disorders of poorly understood origin and are associated with significant morbidity and mortality. A crucial factor associated with IBD onset is the presence of elevated levels of the proinflammatory cytokine tumor necrosis factor (TNF) in the intestine, signified by the use of anti-TNF therapy to treat patients with Crohn’s disease. Despite its pathogenic relevance, the mechanisms regulating TNF expression and IBD onset remain largely unknown. Here, we show that loss of epigenetic regulation results in the induction of TNF in the intestinal epithelium, leading to a loss of intestinal barrier function and inflammation. Our results suggest that mutations in genes controlling epigenetic regulators can lead to IBD onset. |
---|---|
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.1424089112 |